Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Dec 21;23(47):8437-8438.
doi: 10.3748/wjg.v23.i47.8437.

Silymarin: An option to treat non-alcoholic fatty liver disease

Carmela Colica  1 , Luigi Boccuto  2 , Ludovico Abenavoli  3
Affiliations
Comment

Silymarin: An option to treat non-alcoholic fatty liver disease

Carmela Colica et al. World J Gastroenterol. .

Abstract

We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet associated to an antioxidant complex rich in silymarin, to improve in overweight patients anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat accumulation.

Keywords: Antioxidant; Mediterranean diet; Non-alcoholic fatty liver disease; Silymarin.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: Authors declares no conflict of interest related to this publication.

Comment on

References

    1. Singh S, Osna NA, Kharbanda KK. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World J Gastroenterol. 2017;23:6549–6570. - PMC - PubMed
    1. Masarone M, Federico A, Abenavoli L, Loguercio C, Persico M. Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials. 2014;9:126–133. - PubMed
    1. Abenavoli L, Milic N, Di Renzo L, Preveden T, Medić-Stojanoska M, De Lorenzo A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2016;22:7006–7016. - PMC - PubMed
    1. Boccuto L, Abenavoli L. Genetic and Epigenetic Profile of Patients With Alcoholic Liver Disease. Ann Hepatol. 2017;16:490–500. - PubMed
    1. European Association for the Study of the Liver (EASL) European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–1402. - PubMed